home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Protecting Baby

  February, 3 2004 11:20
your information resource in human molecular genetics
Expectant mothers do not typically reject their babies by mounting an immune response. A systemic change occurs in the immune systems of pregnant women that lessens the possibility of fetal rejection as well as other potentially harmful autoimmune reactions. In the March issue of Nature Immunology, British researchers show that pregnancy induces an immune-tolerant state by increasing the number of particular immune cells known as CD4+CD25+ regulatory T cells.

Regulatory T cells act to control other T cells, thereby preventing attack on tissues that might be perceived as foreign by the immune system. Alexander Betz and colleagues found that pregnant mice had two to three times the number of circulating regulatory T cells of nonpregnant age-matched female mice. These increases occurred soon after conception, but waned after birth. When the regulatory T cells were depleted in the pregnant mice, spontaneous rejection of their fetuses occurred. These results suggest that the regulatory T cells might be the principal means by which pregnant mothers tolerate their developing embryos. This research might lead to diagnostic tests for infertile couples who experience recurrent pregnancy losses.

Author contact:
Alexander G. Betz
MRC Laboratory of Molecular Biology
Cambridge, UK)
Tel: +44 1223 402072
E-mail: betz@mrc-lmb.cam.ac.uk

Also available online.

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.